Radacić M, Boranić M, Skarić D, Skarić V, Mihalić H, Gajsak V, Jercić J, Lelieveld P
Oncology. 1987;44(1):34-7. doi: 10.1159/000226439.
To reduce the nephrotoxicity of cis-dichlorodiammineplatinum (cis-DDP) we have used tetrahydroindazolonedicarboxylic acid (HIDA) in doses of 200, 100 or 50 mg/kg 4, 2 and 1 h before or 1, 2 and 4 h after cis-DDP treatment (10 mg/kg). At any dose, given 2 or 1 h before or 1 h after cis-DDP, HIDA reduced the kidney damage as judged by the blood urea nitrogen (BUN) levels in blood. No protective effect was seen when HIDA was given 4 h before cis-DDP injection. Studies in vitro on L1210 cells have revealed that HIDA does not directly interact with cis-DDP.
为降低顺式二氯二氨铂(顺铂)的肾毒性,我们使用了四氢吲唑二羧酸(HIDA),在顺铂治疗(10mg/kg)前4、2或1小时或后1、2和4小时给予200、100或50mg/kg剂量。在任何剂量下,于顺铂给药前2或1小时或给药后1小时给予HIDA,通过血液中尿素氮(BUN)水平判断,HIDA均可减轻肾脏损伤。在顺铂注射前4小时给予HIDA则未见保护作用。对L1210细胞的体外研究表明,HIDA不与顺铂直接相互作用。